NLRP3 and metabolic dysfunction-associated steatotic liver disease: The NLRP3 inflammasome is a crucial factor in processing key pro-inflammatory cytokines, making it a potential target for the prevention and treatment of NAFLD/NASH (Cao et al., 2022).